Abstract

Despite significant advancement in primary percutaneous interventions, cardiogenic shock (CS) remains a clinical challenge in patients with ischemic cardiomyopathy (ICM). Percutaneous mechanical circulatory support devices (MCS) have been increasingly utilized and have become an essential component

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call